Diabetes Medications and Cardiovascular Outcomes in Type 2 Diabetes-Reference-Cited by-同舟云学术

Diabetes Medications and Cardiovascular Outcomes in Type 2 Diabetes

Published:2017-11 Issue:11 Volume:26 Page:1133-1141
ISSN:1443-9506
Container-title:Heart, Lung and Circulation
language:en
Short-container-title:Heart, Lung and Circulation

Author:

Chi Cecilia,Snaith Jennifer,Gunton Jenny E.^ORCID

Funder

NHMRC and Sydney Medical School Foundation

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine

Reference70 articles.

1. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;The Emerging Risk Factors Collaboration;The Lancet,2010

2. Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes;Nissen;N Engl J Med,2007

3. FDA Drug Safety Communication: Updated Risk Evaluation and Mitigation Strategy (REMS) to Restrict Access to Rosiglitazone-containing Medicines including Avandia, Avandamet, and Avandaryl;U.S. Food & Drug Administration,2011

4. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes;Group TAC;N Engl J Med,2008

5. Metformin–mode of action and clinical implications for diabetes and cancer;Pernicova;Nat Rev Endocrinol,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin‐4‐IgG4‐Fc in healthy subjects: A phase 1, single‐centre, randomized, double‐blind, dose escalation study;Diabetes, Obesity and Metabolism;2024-01-29

2. The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study;Expert Opinion on Drug Safety;2023-11-10

3. Cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors: A meta-analysis of cardiovascular outcome trials;World Journal of Cardiology;2021-10-26

4. Hypoxia-inducible factors and diabetes;Journal of Clinical Investigation;2020-09-14

5. Coronary Microvascular Dysfunction in Diabetes – Clinical and Research;Microvascular Disease in Diabetes;2020-03-13